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INTRODUCTION
Cellulite is estimated to affect 80% to 90% of women 
at some point after the age of puberty.1 It occurs mainly 
on the buttocks and upper posterior thighs and is often 
described as having an orange peel, cottage cheese, or 
mattress-like appearance.2 Changes in the fibrous struc-
ture of the skin and increased skin laxity contribute to the 
worsening of cellulite with age,2 particularly in those over 
35 years old.
The cutaneous changes associated with cellulite have 
multiple causes, but certain connective tissue anatomical 
characteristics found in women are thought to predispose 
them to this condition. Fibrous septa cross the subcutane-
ous fatty layer, connecting the reticular dermis to the deep 
fascia. In women, these are usually orientated perpendic-
ularly to the skin surface, creating large, rectangular fat 
lobules.3,4 Shortening of the septa due to fibrosis leads to 
retraction at their cutaneous insertion points, pulling the 
skin down and creating the typical depressions or dimples. 
The raised areas result from projection of underlying fat 
lobules into the dermis.5 In men, the fibrous septa are or-
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Background: Age-associated skin laxity contributes to worsening of cellulite ap-
pearance. This study evaluated the effects of microfocused ultrasound with visual-
ization (MFU-V; Ultherapy) in combination with diluted calcium hydroxylapatite 
(CaHA; Radiesse) on cellulite appearance and on neocollagenesis.
Methods: Twenty women (18–55 years old) with skin laxity and moderate-to-severe 
cellulite on the buttocks and thighs were retrospectively enrolled. MFU-V was ap-
plied using 4 and 7 MHz transducers (25 lines/transducer/site) and immediately 
followed by subdermal CaHA injection (1 ml/buttock or thigh). Photographs at 
baseline and 90 days were assessed by 2 independent, blinded evaluators using a 
5-item cellulite severity scale. One subject scheduled for thighplasty received treat-
ment with 6 different CaHA dilutions (0.3 ml/5 cm2) followed by MFU-V. Tissue 
specimens from each dilution site were examined under polarized light micros-
copy to assess neocollagenesis.
Results: Both evaluators reported statistically significant improvements com-
pared with baseline for each item on the cellulite severity scale (P < 0.001) with 
a 4.5-point improvement in mean overall score (P < 0.001) after a single MFU-V/
CaHA treatment. At 90 days, histologic analysis showed peak neocollagenesis in 
samples treated with the 1:1 dilution, whether with CaHA alone or in combination 
with MFU-V. The highest conversion of collagen type III into collagen type I at 
month 3 occurred in samples injected with 1:1 and 1:0.6 CaHA dilutions without 
subsequent MFU-V treatment. Both procedures were well tolerated, and subject 
satisfaction was high.
Conclusions: Combination treatment with MFU-V and diluted CaHA is effec-
tive for improving skin laxity and the appearance of cellulite on the buttocks 
and upper thighs. (Plast Reconstr Surg Glob Open 2017;5:e1388; doi: 10.1097/
GOX.0000000000001388; Published online 25 July 2017.)
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ganized in a crisscross pattern, which creates smaller sub-
cutaneous fat lobules, an organization that does not favor 
the development of cellulite dimples.6
Cellulite involves a transformation and alteration of 
subcutaneous tissues and is not merely an accumulation 
of fat. A magnetic resonance imaging study of 60 women 
compared raised cellulite dimples with nondimpled con-
trol skin and found that the anatomy of subcutaneous 
fat was similar in both the dimple and control areas for 
shape, size, and thickness.7 Other studies have shown that 
the presence of cellulite corresponds to a thinning of the 
dermal layer, increase in skin laxity, and change in skin 
biomechanical parameters.2,8,9 Individuals with a higher 
body mass index (BMI) may have a weaker, less dense con-
nective tissue structure, leading to increased extrusion of 
subcutaneous fat lobules into the dermis.10,11
The appearance of skin laxity and cellulite can nega-
tively affect an individual’s quality of life. Numerous thera-
peutic approaches with varying degrees of effectiveness 
have been described, including topical products,12,13 ra-
diofrequency,14–16 laser therapy,17–19 and carboxytherapy.20
Increasing strength and elasticity of the dermis and su-
perficial fascia are important aims when treating skin laxity 
to improve the appearance of cellulite;21 such approaches 
require stimulation of new collagen formation and subse-
quent dermal remodeling. Two procedures that have un-
equivocally demonstrated collagen-stimulating properties 
and improvements in skin laxity in a variety of aesthetic in-
dications are microfocused ultrasound with visualization 
(MFU-V, Ultherapy; Ulthera, Inc., Mesa, Ariz.),22–31 and 
injection with calcium hydroxylapatite (CaHA, Radiesse; 
Merz North America, Inc., Raleigh, N.C.).32–35
The aim of the current study was to evaluate whether 
treatment of skin laxity with a combination of MFU-V and 
CaHA would improve the appearance of cellulite on the 
buttocks and thighs. The study also sought to determine 
whether MFU-V would enhance the collagen-stimulating 
properties of CaHA.
METHODS
This was a retrospective study of women who had un-
dergone MFU-V and CaHA treatment for skin laxity on the 
buttocks and thighs between December 2014 and Octo-
ber 2016. The study included healthy women aged 18–55 
years with a BMI less than 25 kg/m2 and moderate-to-se-
vere cellulite on the buttocks and thighs as assessed using 
the Hexsel, Dal’Forno and Hexsel Cellulite Severity Scale 
(CSS).36 Women were also required to have mild-to-severe 
skin laxity on the thighs and a desire for improvement in 
the appearance of their cellulite. Subjects were not eligi-
ble for treatment if they had undergone any treatment for 
skin laxity or cellulite in the last 3 months, had received 
liposuction in the treatment area, or had experienced an 
increase or decrease in body weight of more than 10% in 
the past 6 months. Pregnant or lactating women or those 
planning a pregnancy were also excluded.
All subjects had provided signed, informed consent 
to the procedures. All subjects had also given consent to 
the subsequent use of their photographs being rated, ana-
lyzed, and published for scientific purposes.
Treatment Procedure
The areas to be treated were marked with a pen with 
the subject standing upright, and topical lidocaine (Plia-
glis) was applied. MFU-V was directed to the posterior but-
tocks, lateral buttocks, and posterior thighs using the 4 
MHz transducer at a focal depth of 4.5 mm and the 7 MHz 
transducer at a depth of 3.0 mm, using 75 lines per trans-
ducer for each side (25 lines per buttock or thigh treat-
ment site). Immediately after MFU-V, subjects received 
treatment with 1.5 ml CaHA diluted 1:1 with 1.5 ml of 2% 
lidocaine solution. Using a 25G, 48-mm-long cannula, the 
3.0 ml of diluted CaHA was injected in the subdermis us-
ing a microdroplet fanning technique (1 ml per treatment 
site with 10 lines of 0.1 ml per line) to cover the same area 
as the MFU-V. Vigorous massage of the treatment area was 
performed to ensure even dispersion, and subjects were 
instructed to refrain from exercising the treatment area 
for 24 hours. Photographs were taken before treatment 
and at 90 days.
Assessment of Cellulite Severity
The primary objective was to evaluate the degree of 
skin laxity and cellulite improvement after treatment with 
MFU-V and CaHA. Two independent, blinded evaluators 
assessed cellulite severity from photographs taken at base-
line and 90 days after treatment using the CSS.36 The scale 
identifies 5 key clinical morphologic features of cellulite: 
(1) number of evident depressions, (2) depth of depres-
sions, (3) morphologic appearance of skin surface altera-
tions, (4) grade of laxity, flaccidity or sagging skin, and (5) 
the classification scale originally described by Nürnberger 
and Müller.3 The severity of each item was graded from 0 
to 3, where 0 represented the absence of cellulite and 3 
represented the most severe cellulite changes. This cre-
ated a final sum of scores ranging numerically from 0 to 
15. Based on the final numeric score, cellulite was further 
classified as mild, moderate, or severe.
All subjects completed a patient satisfaction question-
naire 90 days after the procedures. Questions included 
does your skin have no change, is your skin smoother, is 
your skin rougher, are your cellulite dimples less visible, 
are your dimples unchanged, and are your dimples more 
visible? The subjects were required to respond using a 
5-point scale from 1 = very unsatisfied to 5 = very satisfied.
Histologic Analysis
A secondary objective was to determine whether neo-
collagenesis was influenced by different CaHA dilutions 
compared with untreated skin and whether MFU-V en-
hanced the CaHA-induced neocollagenesis. One subject 
had consented to donate skin for a histologic study before 
thighplasty. She received treatment on the inner thigh with 
6 different dilutions of CaHA diluted with 2% lidocaine: 
1:0.16, 1:0.3, 1:0.6, 1:1, 1:2, and 1:6.5. Each inner thigh was 
injected with 0.3 ml of each dilution over an area of 5 cm2. 
The left thigh only received CaHA treatment. On the right 
thigh, each CaHA-treated square and 1 non–CaHA-treated 
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area also received treatment with the MFU-V 4 MHz trans-
ducer at a depth of 4.5 mm and 7 MHz transducer at a 
depth of 3.0 mm at 5 lines per square for each transducer. 
The subject underwent a thighplasty 90 days later.
Tissue specimens from each inner thigh CaHA-injec-
tion site and 1 non–CaHA-treated site were obtained from 
excised skin at the time of thighplasty and fixed by direct 
immersion in a 10% formaldehyde solution before pro-
cessing for light microscopy by dehydration, embedding 
in paraffin, and sectioning. The 6-μm thick sections were 
stained with hematoxylin and eosin to visualize the dif-
ferent skin layers and with picrosirius red solution 0.1% 
(Sirius red F3B, Sigma-Aldrich, St Louis, Mo.) for the den-
sitometric study of collagen.
Histologic sections were analyzed by light microscopy 
at a magnification of 100× with a polarized light source 
using a Zeiss Axio 5 microscope (Carl Zeiss, Oberkochen, 
Germany). Under polarized microscopy, the observed col-
or of collagen fibers stained with picrosirius red depends 
on fiber thickness with thin, newly formed collagen type 
III appearing green, and thick, mature collagen type I 
appearing red.37 The images were captured by a camera 
(Axio Cam), transmitted to a Pentium microcomputer 
and analyzed using the Digimizer 4.5 application (Med-
Calc Software, Acacialaan 22, 8400 Ostend, Belgium). This 
program converts the individual red and green digital im-
ages into binary images, permitting a comparative and 
quantitative evaluation of both mature and newly formed 
collagen fibers in terms of percentage areas occupied by 
red and green in the same reference frame of square pix-
els. This allows the amounts of collagen type I, type III, 
and total collagen (represented by the sum of collagen 
types I and III) to be estimated. All slides were analyzed 
under the same conditions and by the same pathologist.
Statistical Methodology
Statistical analyses were primarily descriptive. Quanti-
tative variables were described using the mean, SD, and 
range. Rating scale scores at each visit were statistically 
compared with baseline scores using the Wilcoxon test for 
related samples. Changes from baseline were considered 
significant at the P < 0.05 level. Analyses were conducted 
using SAS System for Windows (Statistical Analysis System), 
version 9.2 (SAS Institute Inc, 2002–2008, Cary, N.C.).
RESULTS
Demographic Data
A total of 20 women took part in the study and com-
pleted all study visits. Mean age (± SD) was 40.0 ± 8.2 
years (range, 24–52 years) and mean BMI 21.5 ± 1.5 kg/
m2 (range, 19–24 kg/m2). Mean weight was 55.7 ± 4.1 kg 
(range, 50–65 kg) at baseline and 56.1 ± 4.6 kg (range, 50–
68 kg) at 90 days.
Cellulite Severity Scale
Two independent, blinded evaluators assessed cellulite 
severity using the CSS. At baseline, both evaluators rated 
75% of the women as having moderate-to-severe skin de-
pressions. Depression depth was rated as superficial in 
40% of cases and medium-depth to deep in 60%. Appear-
ance was described as “orange peel” in 8 women, “cottage 
cheese” in 5 women, and “mattress-like” in 5 women. Eval-
uators graded 50% of the women as having slight laxity, 
flaccidity, or sagging, and 50% as having moderate-to-se-
vere laxity. Evaluators were also in agreement when grad-
ing women with the Nürnberger and Müller classification, 
with 90% of the women rated as grade 2 or 3 (Table 1).
At day 90, 4 women had no evident depressions, and 11 
had only a small number of depressions compared with 0 
and 5 women, respectively, at baseline. The depth of depres-
sions was also decreased, with 80% of the women having no 
depressions or depressions of superficial depth. Skin surface 
appearance was improved, with 11 women having no raised 
areas compared with 2 at baseline. An “orange peel” appear-
ance was recorded for 8 women at baseline but only 4 at day 
90. A “mattress-like” appearance was reported in 5 women 
at baseline. At day 90, only 1 evaluator used this grade for 1 
subject (Table 1). Overall, 8 women showed no laxity, flac-
cidity, or sagging skin at day 90 compared with 0 at baseline. 
A further 9 or 10 women were rated as having slight skin 
laxity by evaluator 1 and evaluator 2, respectively. Evalua-
tors agreed on improvements in the Nürnberger and Mül-
ler classification at day 90, with 12 subjects having a grade 
1 classification compared with only 2 at baseline. Images il-
lustrating the improvement in cellulite severity 90 days after 
treatment compared with baseline are shown in Figure 1 
and Supplemental Figures 1 and 2 [see pdf, Supplemen-
tal Digital Content 1, which displays photographs before 
(A1, B1) and after (A2, B2) treatment in relaxed position 
(A1, A2) and at maximal squeezing (B1, B2), http://links.
lww.com/PRSGO/A473; see pdf, Supplemental Digital Con-
tent 2, which displays photographs before (A1) and after 
(A2) treatment showing relaxed (upper photograph) and 
clenched (lower photograph) position views and relaxed 
45-degree angle view, http://links.lww.com/PRSGO/A474].
The mean evaluator score for each item and the to-
tal score is displayed in Table 2. When assessing cellulite 
severity 90 days after treatment, both evaluators reported 
statistically significant improvements for each CSS item 
compared with baseline. At 90 days, there was a mean im-
provement in the CSS overall score of 4.5 compared with 
baseline (P < 0.001). The slight difference in weight re-
corded at baseline and at 90 days (55.7 versus 56.1 kg) was 
not statistically significant (P = 0.5).
Patient Satisfaction Score
Subjects were questioned about the perceived effects 
of treatment on their skin. All women reported that they 
could see a change in their skin and that it was smoother. 
Of the 20 women, 19 reported that their dimples were 
less visible and only 1 that their dimples were unchanged. 
When asked to rate their overall satisfaction with the treat-
ment, 10 women (50%) reported they were very satisfied, 
and 9 women (45%) were satisfied.
Histologic Findings
At 90 days, polarized microscope examination of pic-
rosirius red stained tissue sections from skin treated with 
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a range of CaHA dilutions (Fig. 2, bars A1–A6 for CaHA 
alone and B1–B6 for CaHA followed by MFU-V) showed 
that peak total collagen gain occurred with the 1:1 dilu-
tion in both CaHA-treated skin alone and CaHA-treated 
skin followed by MFU-V (Fig. 2, bars A4 and B4, respec-
tively).
In CaHA-treated skin alone, the 1:1 (A4) and 1:0.6 
(A3) dilutions showed the highest conversion to type I col-
lagen at 90 days compared with untreated control tissue 
(C), with increases of 103% and 93%, respectively. When 
CaHA was combined with MFU-V, the 1:1 dilution (B4) 
was associated with a 251% increase in the number of col-
lagen type III fibers compared with control, but conver-
sion to type I collagen was only slightly evident (increase 
of 41%). Picrosirius-red-stained histologic sections of the 
dermis viewed under polarized microscopy are shown in 
Figure 3 for the different CaHA dilutions with or without 
MFU-V treatment.
Safety
MFU-V/CaHA combination treatment was well toler-
ated, with no cases of severe bruising or severe pain. All 
women reported mild pain the day after the procedures 
with a mean duration of 2 days. Mild bruising was observed 
in 18 women and had resolved within 1 week. Other mild 
events observed were erythema (2 women), edema (10 
women), and injection-site induration (5 women), all of 
which resolved in 2‒3 days.
DISCUSSION
In this retrospective study of 20 women with skin laxity 
and moderate-to-severe cellulite, treatment with MFU-V 
and diluted CaHA resulted in a significant improvement 
in cellulite appearance as assessed by 2 independent eval-
uators. Results were consistent between evaluators and 
showed a statistically significant improvement compared 
with baseline for each CSS item, including number and 
depth of depressions, skin surface appearance, degree of 
skin laxity, and grading according to the Nürnberger and 
Müller scale.3 The mean total CSS score improved from 
9.5 ± 3 (moderate-to-severe) at baseline to 5.0 ± 3 (mild) 
at day 90, after only a single MFU-V/CaHA treatment 
session. Both procedures were well tolerated. Transient 
erythema, edema, and bruising were rated as mild and 
resolved within a few days. Pain associated with MFU-V 
treatment was mild. Topical lidocaine was applied, but the 
minimal pain might also reflect the relatively low number 
of lines per treatment site (25 for each transducer). Pa-
tient satisfaction with the procedure was high, with 19 of 
the 20 women reporting that they were satisfied or very 
satisfied with the treatment results.
There is considerable rationale for combining MFU-
V and CaHA to treat skin laxity and thereby improve the 
appearance of cellulite. Both MFU-V and CaHA are skin-
tightening procedures that result in remodeling of the 
dermis and collagenous structures in the superficial fascia 
with neocollagenesis and elastogenesis. MFU-V uses dual 
function transducers to noninvasively deliver microfo-
cused ultrasound energy at preselected depths below the 
skin’s surface while simultaneously providing high-resolu-
tion ultrasound imaging of the skin layers to ensure the 
precision of energy delivery.38 Injection of small amounts 
of diluted CaHA exploits its collagen-stimulating proper-
ties without creating a volumizing effect.32,39,40 The result 
is targeted neocollagenesis in the area of injection.41 Cur-
rent consensus is that MFU-V should be performed first 
but can be followed immediately by CaHA injection.42 The 
rationale for this is to avoid contamination of the MFU-V 
transducers and excess pressure on the injected CaHA.
To evaluate the collagen-stimulating properties of the 
2 procedures, tissue sections from skin injected with 1 of 
6 CaHA dilutions were examined using a combination of 
picrosirius red staining and polarized microscopy, which 
allows newly formed collagen type III and mature colla-
gen type I fibers to be distinguished.43 The maximum total 
Table 1. Number of Patients with CSS Item Grade at Baseline and 90 Days According to the Blinded Evaluators
CSS Item Grade
No. Women with CSS Item Grade
Baseline 90 d
Evaluator 1 Evaluator 2 Evaluator 1 Evaluator 2
No. evident depressions 0 — — 4 4
1 5 5 11 11
2 10 10 4 4
3 5 5 1 1
Depth of depressions 0 — — 5 5
1 8 8 11 11
2 7 7 4 4
3 5 5 — —
Morphological appearance of 
skin surface alterations
0 2 2 11 11
1 8 8 4 4
2 5 5 5 4
3 5 5 — 1
Grade of laxity, flaccidity, or 
sagging skin
0 — — 8 8
1 10 10 10 9
2 7 6 2 3
3 3 4 — —
Nürnberger and Müller clas-
sification
0 — — — —
1 2 2 12 12
2 10 10 6 6
3 8 8 2 2
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collagen gain was observed with the 1:1 CaHA:lidocaine 
dilution, whether from CaHA-treated skin alone or CaHA-
treated skin followed by MFU-V. In CaHA-treated skin 
alone, the 1:1 and 1:0.6 dilutions showed the greatest ef-
fects on type I collagen at 3 months compared with un-
treated control tissue. When CaHA was combined with 
MFU-V, the 1:1 dilution was associated with a 251% in-
crease in collagen type III fibers compared with control. 
However, conversion to collagen type I at 3 months was 
more evident in the tissue sections that were not subject 
to MFU-V, suggesting that thermal coagulation stimula-
tion might lengthen the time required to replace collagen 
type III with collagen type I, probably as a result of the 
greater level of neocollagenesis required. These results 
are supported by a similarly designed study with a 6-month 
period between treatment and histologic analysis, which 
demonstrated increased dermal thickening and more 
dense collagen fibers in skin samples excised from CaHA/
MFU-V combination sites compared with CaHA or MFU-
V sites alone.44 At 3 months, the process of tissue remod-
Fig. 1. Photographs before (a1, B1, C1) and after (a2, B2, C2) treatment in relaxed position (a1, a2), at 
maximal clenching (B1, B2), and at 45-degree angle view (C1, C2).
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elling is still ongoing. Indeed, studies of wound healing 
have shown that during physiological neocollagenesis, the 
remodeling phase in which collagen type III is gradually 
replaced by type I can take up to a year or more.45 A limita-
tion of this pilot study was therefore the short follow-up. 
Both MFU-V and CaHA have demonstrated efficacy in 
their respective treatment indications for periods of 1 year 
or more46,47 and longer follow-up periods may have dem-
onstrated even greater treatment effects and permitted 
the effects of ongoing tissue remodeling to be observed 
at a histologic level. Photographic assessment of cellulite 
appearance can be difficult as the visibility of the dimples 
is dependent on the orientation of the light source and 
the shadows it casts. Consistent light sources and camera 
angles are therefore required. A prospective study is now 
planned with a follow-up period of 1 year to address these 
limitations.
Both MFU-V and CaHA are associated with little down-
time, are FDA approved, and have long-established safety 
profiles in a wide variety of indications. In the current 
study, both treatments were well tolerated, and the histo-
logic analysis did not reveal any foreign body reactions or 
any changes in the appearance or characteristics of CaHA. 
Current evidence suggests that the safety profile of MFU-V 
combined with other aesthetic products including CaHA 
is consistent with the safety profiles of the individual treat-
ments.48
CONCLUSIONS
Combining MFU-V with diluted CaHA produced statis-
tically significant improvements in cellulite severity after 
only a single procedure. By inducing neocollagenesis and 
improving skin laxity, MFU-V and diluted CaHA helped 
Table 2. Assessment of Cellulite Severity by 2 Independent Evaluators Using the Hexsel, Dal’Forno and Hexsel CSS
CSS Item
Evaluator 1 Evaluator 2
Baseline 90 d
Between-Group 
Difference P Baseline 90 d
Between-Group 
Difference P
No. evident depressions 2.00 (0.73) 1.10 (0.79) ˗0.90 (0.31) < 0.001 2.00 (0.73) 1.10 (0.79) ˗0.90 (0.31) < 0.001
Depth of depressions 1.85 (0.81) 0.95 (0.69) ˗0.90 (0.72) < 0.001 1.85 (0.81) 0.95 (0.69) ˗0.90 (0.72) < 0.001
Morphological appearance of 
skin surface alterations
1.65 (0.99) 0.70 (0.86) ˗0.95 (0.60) < 0.001 1.65 (0.99) 0.75 (0.97) ˗0.90 (0.64) < 0.001
Grade of laxity, flaccidity, or 
sagging skin
1.65 (0.75) 0.70 (0.66) ˗0.95 (0.51) < 0.001 1.70 (0.80) 0.75 (0.72) ˗0.95 (0.51) < 0.001
Nürnberger and Müller clas-
sification
2.30 (0.66) 1.50 (0.69) ˗0.80 (0.41) < 0.001 2.30 (0.66) 1.50 (0.69) ˗0.80 (0.41) < 0.001
Overall score 9.45 (2.98) 4.95 (3.02) ˗4.50 (1.00) < 0.001 9.50 (3.07) 5.05 (3.25) ˗4.45 (1.10) < 0.001
Mean scores ± (SD).
Fig. 2. Mean numbers of collagen fibers detected after staining histologic sections with picrosirius red and observing under polarized 
light microscopy. C, control. a, CaHa treatment only. B, CaHa followed by microfocused ultrasound. Dilutions: a1, B1 (1:0.16), a2, B2 
(1:0.3), a3, B3 (1:0.6), a4, B4 (1:1), a5, B5 (1:2), a6, B6 (1:6.5).
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to improve the appearance of the skin dimples typical of 
cellulite. The procedures were well tolerated, and subject 
satisfaction was high. MFU-V and CaHA at a dilution ratio 
of 1:1 are effective in combination for improving skin lax-
ity and cellulite severity in the buttocks and upper thighs.
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